Document Details
Form
Filing Date
Nov 13, 2024
Document Date
Sep 30, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.
